Ameriflex Group Inc. Decreases Stock Holdings in Intuitive Surgical, Inc. $ISRG

Key Points

• Ameriflex Group Inc. has significantly reduced its stake in Intuitive Surgical, Inc. by 66.4%, now holding just 286 shares valued at approximately $153,000 after selling 565 shares during the second quarter.
• Various hedge funds have increased their investments in Intuitive Surgical, with a majority of 83.64% of the company's stock owned by institutional investors.
• Analysts are optimistic about Intuitive Surgical, with 14 providing a "Buy" rating and a consensus price target of $594.19, reflecting expected growth in the company's performance.

Ameriflex Group Inc. decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 66.4% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 286 shares of the medical equipment provider's stock after selling 565 shares during the quarter. Ameriflex Group Inc.'s holdings in Intuitive Surgical were worth $153,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the business. Aaron Wealth Advisors LLC raised its stake in Intuitive Surgical by 0.8% during the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider's stock valued at $1,374,000 after purchasing an additional 19 shares in the last quarter. Crown Wealth Group LLC raised its stake in shares of Intuitive Surgical by 4.8% in the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock valued at $218,000 after acquiring an additional 20 shares during the period. FSM Wealth Advisors LLC raised its stake in shares of Intuitive Surgical by 3.8% in the first quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider's stock valued at $270,000 after acquiring an additional 20 shares during the period. CFO4Life Group LLC raised its stake in shares of Intuitive Surgical by 4.8% in the first quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider's stock valued at $216,000 after acquiring an additional 20 shares during the period. Finally, J. W. Coons Advisors LLC raised its stake in shares of Intuitive Surgical by 1.4% in the first quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider's stock valued at $741,000 after acquiring an additional 20 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several recent analyst reports. Erste Group Bank reissued a "hold" rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. BTIG Research reissued a "buy" rating and issued a $571.00 target price on shares of Intuitive Surgical in a research note on Wednesday. Weiss Ratings reissued a "hold (c+)" rating on shares of Intuitive Surgical in a research note on Saturday, September 27th. Wall Street Zen raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Saturday. Finally, Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a report on Wednesday, July 23rd. Fourteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $594.19.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $452.35 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The stock has a market capitalization of $162.16 billion, a P/E ratio of 63.09, a P/E/G ratio of 4.74 and a beta of 1.61. The company's 50-day simple moving average is $463.55 and its 200-day simple moving average is $500.06.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.35 billion. During the same period last year, the business earned $1.78 EPS. The company's revenue was up 21.4% compared to the same quarter last year. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 4,500 shares of the stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the transaction, the executive vice president directly owned 353 shares of the company's stock, valued at $173,845.44. This trade represents a 92.73% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Amy L. Ladd sold 336 shares of the stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the transaction, the director directly owned 1,074 shares of the company's stock, valued at $504,898.14. The trade was a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock valued at $21,716,492 in the last three months. 0.70% of the stock is owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.